Viewing Study NCT06092268


Ignite Creation Date: 2025-12-24 @ 5:54 PM
Ignite Modification Date: 2025-12-29 @ 6:27 PM
Study NCT ID: NCT06092268
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-10-23
First Post: 2023-10-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-10
Start Date Type: ESTIMATED
Primary Completion Date: 2025-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-12
Completion Date Type: ESTIMATED
First Submit Date: 2023-10-08
First Submit QC Date: None
Study First Post Date: 2023-10-23
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-10-17
Last Update Post Date: 2023-10-23
Last Update Post Date Type: ACTUAL